Page last updated: 2024-08-23

daunorubicin and Blast Crisis

daunorubicin has been researched along with Blast Crisis in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (8.51)	18.7374
1990's	23 (48.94)	18.2507
2000's	13 (27.66)	29.6817
2010's	6 (12.77)	24.3611
2020's	1 (2.13)	2.80

Authors

Authors	Studies
Alkhateeb, H; Badar, T; Gangat, N; Ilyas, R; Mangaonkar, A; McCullough, K; Pardanani, A; Patnaik, MM; Tefferi, A	1
Füreder, W; Gleixner, K; Grünberger, B; Hoermann, G; Kornauth, C; Schwarzinger, I; Sperr, WR; Thalhammer, R; Valent, P	1
Deng, Z; Ding, B; Li, Y; Shi, Y; Zho, J	1
Abdul-Aziz, A; Bowles, KM; Lawes, M; MacEwan, DJ; Pillinger, G; Rushworth, SA; Zaitseva, L	1
Gordon, MJ; Kovacsovics, T; Loriaux, MM; Mayer, LD; Spurgeon, SE; Tardi, P; Traer, E; Tyner, JW	1
Bretscher, C; Cario, G; Fetz, A; Möricke, A; Schrappe, M; Schrauder, A; Stanulla, M	1
Mori, N; Motoji, T; Shiseki, M; Takanashi, M; Tanaka, N; Tsuji, K; Wang, YH	1
Cho, SY; Huh, J; Jun, KR; Kim, B; Kim, HR; Kim, MJ; Lee, JN; Lee, JY; Oh, SH; Park, TS; Shin, JH; Song, SA	1
Berthou, C; Castaigne, S; Cayuela, JM; Cony-Makhoul, P; Deau, B; Gardembas, M; Guerci, A; Guilhot, F; Guilhot, J; Guyotat, D; Hayette, S; Huguet, F; Legros, L; Mahon, FX; Michallet, M; Nicolini, FE; Pautas, C; Réa, D; Rousselot, P; Weiss, IR	1
Borker, A; Ode, D; Yu, L	1
Ascani, S; Bonomini, S; Caramatti, C; Colla, S; Craviotto, L; Crugnola, M; De Celis, I; Giuliani, N; Hojden, M; Morandi, F; Rizzoli, V; Sabbatini, E; Sammarelli, G	1
Hassan, HT; Lu, C	1
Allouche, M; Cariven, C; Chicanne, G; De Toni, F; Demur, C; Manenti, S; Mas, VM; Mesange, F; Payrastre, B; Racaud-Sultan, C; Salles, JP; Ysebaert, L	1
Galski, H; Lazarovici, P; Nagler, A; Sivan, H	1
Mahadevan, D	1
Aleskog, A; Barbany, G; Bengtsson, M; Björnberg, A; Höglund, M; Larsson, R; Lindhagen, E; Olsson-Strömberg, U; Simonsson, B	1
Kouides, PA; Rowe, JM	1
Feldmann, L; Guerci, A; Guerci, O; Marchal, S; Merlin, JL; Missoum, N; Rose, C; Witz, F	1
Kurokawa, H; Nagata, K; Nara, N; Tanikawa, S; Tohda, S; Tomiyama, J	1
Calvert, L; Claxton, D; Durett, A; Giralt, S; Hamer, J; Kantarjian, H; Khouri, I; Liang, J; Talpaz, M; Tibbits, P	1
al-Sabah, A; Baines, P; Burnett, A; Hoy, T; Limaye, M; Padua, RA; Whittaker, J	1
Andreeff, M; Godfrey, L; Hegewisch-Becker, S; Maslak, P	1
Ambrosetti, A; Aprili, F; Krampera, M; Martinelli, G; Meneghini, V; Perona, G; Pizzolo, G; Veneri, D	1
Harbott, J; Lampert, F; Li, L; Lohmeyer, J; Pralle, H; Ritterbach, J; Schroyens, W	1
Cole, SP; Deeley, RG; Doyle, LA; Grant, CE; Lee, EJ; Ross, DD; Schiffer, CA; Tong, Y; Yang, W	1
Grande, M	1
Dunphy, CH; Kitchen, S; Saravia, O; Velasquez, WS	1
Kuyama, J; Take, H	1
Gieseler, F; Glasmacher, A; Kämpfe, D; Kunze, J; Nuessler, V; Valsamas, S; Wandt, H; Wilms, K	1
Jowitt, SN; Yin, JA	1
Chen, H; Choi, CH; Hedley, DW; Ling, V; Minden, MD; Xie, SX	1
de Witte, T; Pennings, AH; Raymakers, RA; Smeets, ME; Vierwinden, G; Wessels, H	1
Elgie, AW; Lewandowicz, GM; Sargent, JM; Taylor, CG; Williamson, CJ	1
Langabeer, S; Pallis, M; Russell, NH; Turzanski, J	1
Hokland, P; Kristensen, JS; Nørgaard, JM; Olesen, G; Pedersen, B	1
Kasimir-Bauer, S; Scheulen, ME; Schröder, JK; Seeber, S	1
Druker, BJ; Kolibaba, KS; Ohno-Jones, S; Thiesing, JT	1
Boos, J; Creutzig, U; Feldges, A; Gadner, H; Hermann, J; Kühl, J; Niemeyer, CM; Ritter, J; Sawatzki, DB; Schwabe, D; Selle, B; Zimmermann, M	1
Erikson, C; Florschütz, A; Rosahl, W; Schreiber, J; Schumann, HJ; Zugehör, M	1
Chan, TK; Chiu, E; Liang, R; Todd, D	1
Kawakubo, K; Ohto, T; Ohyashiki, JH; Ohyashiki, K; Tauchi, T; Toyama, K	1
Beran, M; Deisseroth, A; Estey, EH; Gutterman, J; Kantarjian, HM; Keating, MJ; Kontoyiannis, D; O'Brien, S; Rios, MB; Talpaz, M	1
Beran, M; Estey, EH; Freireich, EJ; Gutterman, J; Kantarjian, HM; Keating, MJ; McCredie, KB; O'Brien, S; Talpaz, M	1
Andreeff, M; Berman, E; Gabrilove, J; Gee, T; Gulati, S; Heller, G; Kempin, SJ; Kolitz, J; Raymond, V; Young, CW	1
Furukawa, Y; Inoue, T; Kishida, T; Kojima, K; Sagawa, H; Sannomiya, Y; Sasaki, A; Yamane, T; Yokomatsu, Y; Yoshikawa, T	1
Kimura, I; Kitani, T; Masaoka, T; Meguro, S; Nagai, K; Ogawa, M; Ohnoshi, T; Sampi, K; Wakui, A; Yamada, K	1
Carcassonne, Y; Dufour, P; Harousseau, JL; Hayat, M; Hurteloup, P; Jaubert, J; Le Prise, PY; Monconduit, M; Reiffers, J; Rigal-Huguet, F	1

Reviews

2 review(s) available for daunorubicin and Blast Crisis

Article	Year
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia. European journal of haematology, 2004, Volume: 72, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Humans; Imatinib Mesylate; Immunophenotyping; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Piperazines; Pyrimidines; Remission Induction	2004
Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature. American journal of hematology, 1996, Volume: 51, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 5; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Flow Cytometry; Humans; Immunophenotyping; Male; Mercaptopurine; Methotrexate; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Primary Myelofibrosis; Remission Induction; Vincristine	1996

Article

Year

Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.

European journal of haematology, 2004, Volume: 72, Issue:5

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Humans; Imatinib Mesylate; Immunophenotyping; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Piperazines; Pyrimidines; Remission Induction

2004

Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.

American journal of hematology, 1996, Volume: 51, Issue:1

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 5; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Flow Cytometry; Humans; Immunophenotyping; Male; Mercaptopurine; Methotrexate; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Primary Myelofibrosis; Remission Induction; Vincristine

1996

Trials

4 trial(s) available for daunorubicin and Blast Crisis

Article	Year
Homoharringtonine combined with cytarabine to treat chronic myelogenous leukemia in myeloid blast crisis and its impact on bone marrow CD34+CD7+ cells. Acta haematologica, 2014, Volume: 132, Issue:2 Topics: Adolescent; Adult; Antigens, CD34; Antigens, CD7; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Cell Count; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Harringtonines; Hematologic Diseases; Homoharringtonine; Humans; Immunophenotyping; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged; Mitoxantrone; Myeloid Cells; Neoplastic Stem Cells; Remission Induction; Young Adult	2014
The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study). Leukemia research, 2011, Volume: 35, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Combined Modality Therapy; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Exanthema; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neutropenia; Piperazines; Prospective Studies; Pyrimidines; Survival Analysis; Treatment Outcome; Young Adult	2011
Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group. Leukemia, 2001, Volume: 15, Issue:3 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Treatment Outcome	2001
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center. Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction	1989

Other Studies

41 other study(ies) available for daunorubicin and Blast Crisis

Article	Year
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases. Blood cancer journal, 2023, 02-17, Volume: 13, Issue:1 Topics: Blast Crisis; Cytarabine; Daunorubicin; Humans; Mutation; Myeloproliferative Disorders	2023
Major response of PNH to an AML chemotherapy protocol. Annals of hematology, 2018, Volume: 97, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Blast Crisis; Cytarabine; Daunorubicin; Hemoglobinuria, Paroxysmal; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction	2018
Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia. Scientific reports, 2015, Aug-21, Volume: 5 Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Apoptosis; Blast Crisis; Cell Line, Tumor; Cell Survival; Daunorubicin; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mutation; Piperidines; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; RNA, Small Interfering; Signal Transduction	2015
CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation. Leukemia research, 2017, Volume: 53 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Daunorubicin; fms-Like Tyrosine Kinase 3; Humans; Inhibitory Concentration 50; Liposomes; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured	2017
Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia. Annals of hematology, 2008, Volume: 87, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Child; Daunorubicin; Gene Expression Profiling; Humans; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reverse Transcriptase Polymerase Chain Reaction; Vincristine	2008
Level of DNA topoisomerase IIalpha mRNA predicts the treatment response of relapsed acute leukemic patients. Leukemia research, 2009, Volume: 33, Issue:7 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antigens, Neoplasm; Blast Crisis; Cell Cycle; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Treatment Outcome; Young Adult	2009
Acute myeloid leukemia associated with t(10;17)(p13-15;q12-21) and phagocytic activity by leukemic blasts: a clinical study and review of the literature. Cancer genetics and cytogenetics, 2010, Oct-01, Volume: 202, Issue:1 Topics: Adolescent; Adult; Antigens, CD; Antimetabolites, Antineoplastic; Blast Crisis; Child; Chromosome Mapping; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Magnetic Resonance Imaging; Male; Middle Aged; Peroxidase; Phagocytes; Translocation, Genetic	2010
Blast crisis of chronic myeloid leukemia: diagnosis prompted by T(8;9). Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:8 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Child, Preschool; Chromosomes, Human, Pair 8; Chromosomes, Human, Pair 9; Combined Modality Therapy; Cytarabine; Daunorubicin; Ethmoid Sinus; Etoposide; Fusion Proteins, bcr-abl; Humans; Karyotyping; Leukemia, Myeloid, Accelerated Phase; Male; Meninges; Mitoxantrone; Remission Induction; Sacrococcygeal Region; Sarcoma, Myeloid; Thioguanine; Translocation, Genetic	2002
Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. Leukemia research, 2006, Volume: 30, Issue:3 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, CD34; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; Biomarkers, Tumor; Blast Crisis; Cell Line, Tumor; Chromosome Aberrations; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Leukemia, Myeloid, Acute; Male; Pilot Projects; Receptors, Cytokine; Stem Cell Factor; Treatment Outcome	2006
A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene, 2006, May-25, Volume: 25, Issue:22 Topics: Antibiotics, Antineoplastic; Blast Crisis; Cell Adhesion; Cell Survival; Cells, Cultured; Culture Media, Conditioned; Daunorubicin; Drug Resistance, Neoplasm; Fibronectins; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Intercellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; Membrane Proteins; NF-kappa B; Osteoblasts; RNA, Small Interfering; Signal Transduction; U937 Cells; Wnt Proteins	2006
In vitro and in vivo reversal of MDR1-mediated multidrug resistance by KT-5720: implications on hematological malignancies. Leukemia research, 2006, Volume: 30, Issue:9 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Carbazoles; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Mice, Transgenic; Multiple Myeloma; Pyrroles	2006
Will MDR-1/P-gp modulators provide clinical benefit in hematologic malignancies? Leukemia research, 2006, Volume: 30, Issue:9 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Carbazoles; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Mice, Transgenic; Multiple Myeloma; Pyrroles	2006
Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis. Anti-cancer drugs, 2006, Volume: 17, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzamides; Blast Crisis; Cytarabine; Daunorubicin; Feasibility Studies; Harringtonines; Homoharringtonine; Humans; Imatinib Mesylate; In Vitro Techniques; Interferons; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oxides; Piperazines; Pyrimidines; Vincristine	2006
A dose intensive regimen of cytosine arabinoside and daunorubicin for chronic myelogenous leukemia in blast crisis. Leukemia research, 1995, Volume: 19, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged	1995
Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood, 1995, Apr-15, Volume: 85, Issue:8 Topics: Acute Disease; Adolescent; Adult; Aged; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Blood Cell Count; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Gene Expression; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Monosomy; Myelodysplastic Syndromes; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Prognosis; Prospective Studies; Quinine; Remission Induction; Risk; Salvage Therapy; Treatment Outcome	1995
The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia. Experimental hematology, 1995, Volume: 23, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Colony-Stimulating Factors; Daunorubicin; Female; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Hematopoietic Stem Cells; Heparin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Recombinant Proteins	1995
Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autolog Blood, 1995, Jun-01, Volume: 85, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Cell Survival; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Diploidy; Etoposide; Female; Genetic Markers; Hematopoietic Stem Cells; Humans; Idarubicin; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Mitoxantrone; Neoplastic Stem Cells; Philadelphia Chromosome; Remission Induction; Survival Rate; Vidarabine; Whole-Body Irradiation	1995
In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations. Leukemia research, 1994, Volume: 18, Issue:9 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow; Bone Marrow Cells; Cell Survival; Cells, Cultured; Cyclosporine; Daunorubicin; Drug Resistance; Drug Resistance, Multiple; Female; Fluorescent Antibody Technique; Humans; Idarubicin; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Male; Middle Aged; Monocytes; Reference Values	1994
Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia. Cytometry, 1994, Sep-01, Volume: 17, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blast Crisis; Child; Child, Preschool; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Treatment Failure; Tumor Cells, Cultured; Verapamil; Vinblastine; Vincristine	1994
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha. International journal of clinical & laboratory research, 1994, Volume: 24, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Child; Cytarabine; Daunorubicin; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Prednisone; Recombinant Proteins; Remission Induction; Vincristine	1994
Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11). Cancer genetics and cytogenetics, 1993, Jul-15, Volume: 68, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Chromosome Banding; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Daunorubicin; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Translocation, Genetic; Vincristine	1993
Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. Leukemia, 1996, Volume: 10, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Base Sequence; Blast Crisis; Daunorubicin; Drug Resistance, Multiple; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	1996
Central nervous system granulocytic sarcoma in a patient with essential thrombocythemia. American journal of hematology, 1996, Volume: 51, Issue:1 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blast Crisis; Bone Marrow; Busulfan; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease Progression; Epidural Space; Fatal Outcome; Frontal Bone; Humans; Leukemia, Myeloid; Leukemic Infiltration; Male; Methylprednisolone; Spinal Canal; Thrombocythemia, Essential	1996
[Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:12 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Daunorubicin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Prednisolone	1995
Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines. Leukemia, 1996, Volume: 10, Issue:7 Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Blast Crisis; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Humans; Hydrogen-Ion Concentration; Idarubicin; Isoenzymes; Leukemia, Myeloid, Acute; Poly-ADP-Ribose Binding Proteins; Prognosis; Tumor Cells, Cultured	1996
Clonality switch in acute myeloid leukemia. Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2 Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Clone Cells; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Progression; Dosage Compensation, Genetic; Female; Hematopoiesis; Heterozygote; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Prednisolone; Remission Induction; Thioguanine; Vincristine	1996
A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia. Leukemia, 1997, Volume: 11, Issue:1 Topics: Acute Disease; Adenosine Triphosphate; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Cyclosporine; Daunorubicin; Flow Cytometry; Humans; Leukemia, Myeloid; Potassium Cyanide; RNA, Messenger; Tumor Cells, Cultured	1997
Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance. Blood, 1999, Oct-01, Volume: 94, Issue:7 Topics: Antibiotics, Antineoplastic; Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow Cells; Cell Cycle; Cell Division; Cell Survival; Cells, Cultured; Daunorubicin; Drug Resistance, Multiple; Gene Expression Regulation; Hematopoietic Stem Cells; Humans; Idarubicin; Idoxuridine; Leukemia, Myeloid, Acute; Verapamil	1999
Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML. Advances in experimental medicine and biology, 1999, Volume: 457 Topics: Acridines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow; Cell Survival; Cyclosporine; Daunorubicin; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Recurrence; Tetrahydroisoquinolines; Tumor Cells, Cultured	1999
Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts. Advances in experimental medicine and biology, 1999, Volume: 457 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blast Crisis; Bone Marrow Cells; Cyclosporine; Cyclosporins; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Genes, MDR; Humans; Leukemia, Myeloid, Acute; Multidrug Resistance-Associated Proteins; Reproducibility of Results	1999
Leukaemia cell drug resistance and prognostic factors in AML. European journal of haematology, 1999, Volume: 63, Issue:4 Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Blast Crisis; Child; Child, Preschool; Cytarabine; Cytogenetic Analysis; Daunorubicin; Drug Resistance, Neoplasm; Female; Humans; Infant; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Prognosis; Tetrazolium Salts	1999
In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia. Journal of cancer research and clinical oncology, 2000, Volume: 126, Issue:2 Topics: Antineoplastic Agents; Blast Crisis; Calcium Channel Blockers; Daunorubicin; Dihydropyridines; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Idarubicin; Leukemia, Myeloid, Acute; Tumor Cells, Cultured; Verapamil	2000
Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells. Blood, 2000, Nov-01, Volume: 96, Issue:9 Topics: Antineoplastic Agents; Benzamides; Blast Crisis; Cell Division; Cell Survival; Cytarabine; Daunorubicin; Fusion Proteins, bcr-abl; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxyurea; Imatinib Mesylate; Interleukin-3; Leukemia, Megakaryoblastic, Acute; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcr; Pyrimidines; Stem Cell Factor; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay	2000
[Primary pulmonary manifestation of extramedullary acute myelocytic leukemia]. Pneumologie (Stuttgart, Germany), 2001, Volume: 55, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bronchoalveolar Lavage Fluid; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Middle Aged; Prednisolone; Radiography; Thioguanine; Vincristine	2001
Non-aggressive therapy for chronic myeloid leukaemia in blastic transformation. Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Remission Induction; Thioguanine; Vincristine	1992
Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon. Cancer genetics and cytogenetics, 1992, Volume: 58, Issue:2 Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marrow; Chromosome Aberrations; Chromosome Banding; Daunorubicin; Gene Rearrangement; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Prednisolone; Remission Induction; Vincristine	1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Diseases; Cytarabine; Daunorubicin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Middle Aged; Prognosis; Remission Induction; Survival Analysis	1992
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Cancer, 1991, Sep-15, Volume: 68, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Drug Resistance; Female; Follow-Up Studies; Humans; Interferon Type I; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Pilot Projects; Prednisone; Survival Rate; Vincristine	1991
[Differentiating effect of the oral administration of vitamin D and vitamin A in acute myelocytic leukemia after BHAC-DMP therapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1988, Volume: 29, Issue:5 Topics: Administration, Oral; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Prednisolone; Vitamin A; Vitamin D	1988
[Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:10 Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Aged; Blast Crisis; Child; Daunorubicin; Drug Evaluation; Drug Resistance; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Naphthacenes	1986
Idarubicin in the treatment of relapsed or refractory acute myeloid leukemia. Cancer treatment reports, 1987, Volume: 71, Issue:10 Topics: Adolescent; Adult; Aged; Blast Crisis; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged	1987